UK Tobacco and Vapes Bill to Ban Tobacco Sales to Those Born After 2009, Effective 2027

Nov.14.2024
UK Tobacco and Vapes Bill to Ban Tobacco Sales to Those Born After 2009, Effective 2027
The UK's Tobacco and Vapes Bill plans to gradually ban the sale of tobacco products to those born on or after January 1, 2009, and strengthen regulations on vapes and nicotine products, including introducing a licensing system and increasing fines for violations.

On November 13th, the UK government website released a document titled "Tobacco and Vapes Bill: creating a smoke-free UK and tackling youth vaping factsheet". This legislation will be a milestone in the UK's efforts to become a smoke-free nation.

 

The bill aims to gradually ban the sale of tobacco products and introduce a smoke-free generation nationwide. Selling tobacco products, herbal smoking products, and cigarette papers to individuals born on or after 1 January 2009 will be illegal. Children born on or after this date will never be able to be legally sold tobacco products, breaking the cycle of addiction and disadvantage.

 

The products in scope include:

 

 

  • cigarettes
  • hand rolled tobacco
  • cigars
  • cigarillos
  • pipe tobacco
  • waterpipe tobacco products (for example, shisha)
  • chewing tobacco
  • heated tobacco
  • nasal tobacco (snuff)
  • herbal smoking products
  • cigarette papers

 

 

Display, sales, and advertising restrictions:

 

 

In addition, the bill will also prohibit all vape and other nicotine products (such as nicotine pouches) from advertising and sponsorship, following strict restrictions similar to those imposed on tobacco.

 

The bill will fill a gap by banning the sale of all vapes and nicotine products to those under 18 years old, as well as prohibiting the free distribution of these products and sales through vending machines.

 

The minister will also have the authority to regulate the flavors, packaging, and display of vapes and other nicotine products, as well as the power to modify and update product standards.

 

 

Expanding existing legislation

 

 

The Tobacco and Vapes Bill will also extend existing indoor smoking restrictions to certain outdoor public spaces and workplaces. The government is considering expanding smoke-free areas to include areas outside of schools, children's playgrounds, and hospitals, but will not cover outdoor dining areas or beaches and other broader open spaces. Specific locations that should be smoke-free will be determined through secondary legislation and will undergo thorough consultation.

 

In addition, smoke-free places also prohibit vapes and heated tobacco products.

 

 

Strict law enforcement and product registration system

 

 

Furthermore, the bill will enhance enforcement efforts and support the implementation of the above measures. It will empower the introduction of a specific licensing regime for retail tobacco products, herbal smoking products, rolling papers, vapes, and nicotine products in England, Wales, and Northern Ireland. The bill also strengthens Scotland's existing retail registration, expanding it to include herbal smoking products and nicotine products.

 

It will also give enforcement agencies in England and Wales the power to issue Fixed Penalty Notices (FPNs) of up to £200 for illegal activities, including selling tobacco and vape products to minors, and £2,500 FPNs for offences in connection with licensing.

 

The government will also be given the authority to introduce a new product registration system for tobacco, vaps, and nicotine products. This system will outline requirements for producers and manufacturers before their products are sold to consumers.

 

 

Geographical scope

 

 

The bill will apply to the entire UK and will create a coordinated and consistent regulatory framework for tobacco and vape products, building on existing legislation in the four constituent countries. The UK government worked in partnership with the Scottish government, the Welsh government, and the Northern Ireland Executive to develop the bill. 

 

Under the devolution agreement, measures vary across the UK, with Wales and Scotland already making further progress in smoke-free areas, banning smoking outside hospitals. Wales has also implemented smoke-free policies outside hospitals and school grounds.

 

Subject to approval from Parliament, the age of sale restrictions for tobacco will come into force on 1 January 2027, when those born on 1 January 2009 turn 18.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09